Clinical Trial Update: Trial of Dacarbazine With or Without Genasense in Advanced Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing dacarbazine with or without Genasense in advanced melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Genasense (oblimersen)

Snippet

Sponsor: Genta Incorporated | Conditions: Melanoma | Phase 3 | Status: COMPLETED